Histogen Inc. Annual Earnings Per Share, Diluted in USD/shares from 2011 to 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Histogen Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2011 to 2022.
  • Histogen Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2023 was -0.9 USD/shares, a 10.9% increase year-over-year.
  • Histogen Inc. Earnings Per Share, Diluted for the twelve months ending September 30, 2023 was -2.83 USD/shares.
  • Histogen Inc. annual Earnings Per Share, Diluted for 2022 was -3.46 USD/shares, a 55.6% increase from 2021.
  • Histogen Inc. annual Earnings Per Share, Diluted for 2021 was -7.79 USD/shares.
  • Histogen Inc. annual Earnings Per Share, Diluted for 2013 was -0.63 USD/shares, a 92.7% increase from 2012.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$3 +$4.33 +55.6% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-09
2021 -$8 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2013 -$1 +$7.97 +92.7% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-28
2012 -$9 +$3.26 +27.5% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-28
2011 -$12 Jan 1, 2011 Dec 31, 2011 10-K 2014-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.